These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 11026601)
1. Immunohistochemical localization of transforming growth factor alpha in chemically induced rat hepatocellular carcinomas with reference to differentiation and proliferation. Kobayashi K; Kusakabe M; Okada M; Sakairi T; Goto K; Tsuchiya T; Sugimoto J; Sano F; Mutai M Toxicol Pathol; 2000; 28(5):664-7. PubMed ID: 11026601 [TBL] [Abstract][Full Text] [Related]
2. Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen. Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M Toxicol Pathol; 2001; 29(4):479-82. PubMed ID: 11560253 [TBL] [Abstract][Full Text] [Related]
3. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Santoni-Rugiu E; Jensen MR; Thorgeirsson SS Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068 [TBL] [Abstract][Full Text] [Related]
4. An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation. Kagawa M; Sano T; Ishibashi N; Hashimoto M; Okuno M; Moriwaki H; Suzuki R; Kohno H; Tanaka T Carcinogenesis; 2004 Jun; 25(6):979-85. PubMed ID: 14742314 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci. Steinmetz KL; Klaunig JE Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879 [TBL] [Abstract][Full Text] [Related]
6. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital. Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323 [TBL] [Abstract][Full Text] [Related]
9. Abundant TGF alpha precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Tanno S; Ogawa K Carcinogenesis; 1994 Aug; 15(8):1689-94. PubMed ID: 7914477 [TBL] [Abstract][Full Text] [Related]
10. Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats. Ando N; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Tanaka T; Moriwaki H Oncol Rep; 2007 Oct; 18(4):879-84. PubMed ID: 17786350 [TBL] [Abstract][Full Text] [Related]
11. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Calvisi DF; Factor VM; Loi R; Thorgeirsson SS Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of transforming growth factor alpha in regenerating rat liver. Okada M; Sakairi T; Kusakabe M; Goto K; Tsuchiya T; Sugimoto J; Sano F; Mutai M; Morohashi T; Kobayashi K J Vet Med Sci; 2002 Nov; 64(11):1045-8. PubMed ID: 12499692 [TBL] [Abstract][Full Text] [Related]
13. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Moser GJ; Wolf DC; Goldsworthy TL Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259 [TBL] [Abstract][Full Text] [Related]
14. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver. Lee TY; Kim KT; Han SY Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis. Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595 [TBL] [Abstract][Full Text] [Related]
16. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879 [TBL] [Abstract][Full Text] [Related]
17. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats. Ohshima M; Ward JM; Brennan LM; Creasia DA J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458 [TBL] [Abstract][Full Text] [Related]
18. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051 [TBL] [Abstract][Full Text] [Related]
19. Histochemical and cytochemical study of butyrylcholinesterase activity in rat hepatocellular carcinomas induced by 3'-methyl-4-dimethylaminoazobenzene. Yokoyama S; Kaneko A; Dempo K; Chisaka N; Mori M; Onoe T Cancer Res; 1982 Oct; 42(10):4158-63. PubMed ID: 7105011 [TBL] [Abstract][Full Text] [Related]
20. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies. Christensen ME Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]